121
Views
5
CrossRef citations to date
0
Altmetric
Review

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients

&
Pages 1019-1030 | Published online: 03 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carlo Finelli, Sarah Parisi & Stefania Paolini. (2022) Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights. Expert Review of Hematology 15:5, pages 411-421.
Read now

Articles from other publishers (4)

Charalampos G. Pontikoglou, Angelos Matheakakis & Helen A. Papadaki. (2023) The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting. Frontiers in Oncology 13.
Crossref
Johanne Rozema, Ivar van Asten, Beau Kwant, Robby E. Kibbelaar, Nic J. G. M. Veeger, Harry de Wit, Eric N. van Roon & Mels Hoogendoorn. (2022) Clinical view versus guideline adherence in ferritin monitoring and initiating iron chelation therapy in patients with myelodysplastic syndromes. European Journal of Haematology 109:6, pages 772-778.
Crossref
Valentina Granata, Laura Crisafulli, Claudia Nastasi, Francesca Ficara & Cristina Sobacchi. (2022) Bone Marrow Niches and Tumour Cells: Lights and Shadows of a Mutual Relationship. Frontiers in Immunology 13.
Crossref
Abdalla saleh Awidi, Marah Alzu’bi, Nada Odeh, Jawad Alrawabdeh, Muntaser Al Zyoud, Yazan Hamadneh, Hisham Bawa'neh, Ahmad Magableh, Alaa Alshorman, Feras Al-Fararjeh, Tariq N. Al-Adily & Amer Zeidan. (2022) Myelodysplastic Syndrome: A Real-World Experience from a Developing Country. SSRN Electronic Journal.
Crossref